Diffuse Large B-Cell Lymphoma (DLBCL) is an aggressive type of non-Hodgkin's lymphoma and has a poor prognosis, but still has the potential to be cured with combination chemotherapy, but has a high rate of resistance and recurrence. Resistance to apoptosis is the main reason for the occurrence of chemoresistance in DLBCL is associated with the inhibition of the modulation of the apoptotic signaling pathway. Pasak bumi (Eurycoma longifolia) is one of the native Indonesian plants which has anti-cancer potential by inducing the apoptosis pathway mechanism, with one of the contents of pasak bumi root, namely eurycomanol which has been proven to be cytotoxic in solid tumors. Protein tracking was carried out using the UniProt database (https://www.uniprot.org/), with the bioactive components of pasak bumi and STAT-3 as target proteins. Molecular docking was carried out using Patchdock Server and antioxidant activity (https://services.healthtech.dtu.dk/service.php?AnOxPePred-1.0) to determine affinity and interactions with target proteins in cancer cells. Researchers found that the peptide (quassionoid/flavonoid) eurycomanol content in pasak bumi has the potential to modulate apoptosis pathway in its role as an anti-cancer through stimulation of pro-apoptotic genes and inhibition of anti-apoptotic genes by activating JAK-STAT Pathways.
Keywords: DLBCL - JAK-STAT pathway - Apoptosis - Eurycoma longifolia
How to cite this article: Kurniawan SP, Oktaviyanti IK, Panghiyangani R, Prenggono MD, Huldani H; The Role of Eurycoma longifolia (Pasak Bumi) in Modulating the Apoptosis Pathway in Diffuse Large B-Cell Lymphoma (DLBCL): In silico study on JAK-STAT Pathways. Int J Drug Deliv Technol. 2026;16(1): 421-428. DOI: 10.25258/ijddt.16.1.44